Richard Bethlehem is a postdoctoral fellow and research associate at the Autism Research Centre and Brain Mapping Unit at the University of Cambridge in the United Kingdom. He studies integrated neuroimaging and transcriptomics to gain better understanding of the biological underpinnings of typical and atypical neurodevelopment.
Richard Bethlehem
Research associate
University of Cambridge
From this contributor
Q&A with Richard Bethlehem: What goes into a Brainhack
Brainhack conferences offer talks and hands-on tutorials, and unite small groups of interdisciplinary researchers to work on open-source neuroscience projects.
Q&A with Richard Bethlehem: What goes into a Brainhack
By
Niko McCarty
9 July 2021 | 7 min read
How normative modeling can reframe autism’s heterogeneity
Normative modeling could capture variability among autistic people and allow for individualized assessments.
How normative modeling can reframe autism’s heterogeneity
By
Richard Bethlehem, Andre F. Marquand
25 February 2020 | 4 min read
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
By
Holly Barker
29 January 2026 | 4 min read
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read